Therapeutic Asset Ratings
136 results matching 1 filter
133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
1-(2,8-DIMETHYL-1-THIA-3,8-DIAZASPIRO(4.5)DEC-3-YL)-3-(1H-INDOL-3-YL)PROPAN-1-ONE
Schizophrenia
Anavex Life Sciences Corp.
P2
CCC
(48)
Alto-101
Schizophrenia
Alto Neuroscience
P2
CCC
(48)
Anavex3-71 Capsules
Schizophrenia
Anavex Life Sciences Corp.
P2
CCC
(48)
br5402a
Schizophrenia
Boryung Pharmaceutical Co., Ltd
P2
CCC
(48)
BR5402A-1
Schizophrenia
Boryung Pharmaceutical Co., Ltd
P2
CCC
(48)
br5402b
Schizophrenia
Boryung Pharmaceutical Co., Ltd
P2
CCC
(48)
BR5402B-1
Schizophrenia
Boryung Pharmaceutical Co., Ltd
P2
CCC
(48)
br5402c
Schizophrenia
Boryung Pharmaceutical Co., Ltd
P2
CCC
(48)
br5402c-1
Schizophrenia
Boryung Pharmaceutical Co., Ltd
P2
CCC
(48)
br5402d
Schizophrenia
Boryung Pharmaceutical Co., Ltd
P2
CCC
(48)
br5402d-1
Schizophrenia
Boryung Pharmaceutical Co., Ltd
P2
CCC
(48)
Brenipatide
Schizophrenia
Eli Lilly and Company
P2
CCC
(48)
Buprenorphine
Schizophrenia
University of California, Los Angeles
P2
CCC
(48)
CLEMASTIN
Schizophrenia
LMU Klinikum
P2
CCC
(48)
Dasatinib
Schizophrenia
Washington University School of Medicine
P2
CCC
(48)
DEXTROSE
Schizophrenia
Beth Israel Deaconess Medical Center
P2
CCC
(48)
FLAVONE, 3,3',4',5,7-PENTAHYDROXY-
Schizophrenia
Washington University School of Medicine
P2
CCC
(48)
gxv813
Schizophrenia
Novartis Pharmaceuticals
P2
CCC
(48)
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Schizophrenia
Uppsala University Hospital
P2
CCC
(48)
ml-007c-ma
Schizophrenia
MapLight Therapeutics
P2
CCC
(48)
Nbi-1117570
Schizophrenia
Neurocrine Biosciences
P2
CCC
(48)
S1RA
Schizophrenia
China Medical University Hospital
P2
CCC
(48)
spg302
Schizophrenia
Spinogenix
P2
CCC
(48)
Tirzepatide
Schizophrenia
Anders Fink-Jensen, MD, DMSci
P2
CCC
(48)
ly03010
Schizophrenia
Luye Pharma Group Ltd.
P1
CCC
(48)
Showing 76 to 100 of 136 assets
Previous
Page 4 of 6
Next